Read + Share
Amedeo Smart
Independent Medical Education
Unger JM, Qian L, Redman MW, Tavernier SS, et al. Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. J Natl Cancer Inst 2023;115:437-446.PMID: 36625510
Email
LinkedIn
Facebook
Twitter
Privacy Policy